Federal health officials say the ultra-rare blood clots reported in six people who received Johnson & Johnson’s COVID-19 vaccine are similar to blood clots detected in a very small number of people in Europe who were immunized with AstraZeneca’s shot.

View Article Here MarketWatch.com – Top Stories